| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/10/2008 | US20080167256 Double-stranded RNA (siRNA) capable of suppressing expression of Skp-2 gene; small cell lung cancer |
| 07/10/2008 | US20080167253 Antiinflammatory agents; antiarthritic agents; antiscarring agents; isolated oligopeptide which can be obtained from the microorganism Entamoeba histolytica or synthesized |
| 07/10/2008 | US20080167246 Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative |
| 07/10/2008 | US20080167245 Novel metastasis suppressor gene on human chromosome 8 |
| 07/10/2008 | US20080167243 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
| 07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167238 Albumin Fusion Proteins |
| 07/10/2008 | US20080167237 Methods and compositions for healing and repair of articular cartilage |
| 07/10/2008 | US20080167236 Methods and compositions for healing and repair of articular cartilage |
| 07/10/2008 | US20080167235 Methods and compositions for healing and repair of articular cartilage |
| 07/10/2008 | US20080167234 Polypeptide does not contain a vertebrate high mobility group box protein (hmgb), that inhibit the release of a proinflammatory cytokine; treating inflammatory disease, autoimmune disease with monoclonal antibody or antigen-binding fragment |
| 07/10/2008 | US20080167232 Anti-angiogenic and anti-tumor properties of vascostatin and other indogen domains |
| 07/10/2008 | US20080167228 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167226 solution contains GLP-1(7-37) or an analogue wherein an amino acid residue of the parent peptide has a lipophilic substituent attached optionally via a spacer; pH is 7-10; stability, long shelf life; biodrug for stimulating insulin secretion, lowing blood glucose |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080167221 Heterocarpine, a plant-derived protein with anti-cancer properties |
| 07/10/2008 | US20080167219 converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor |
| 07/10/2008 | US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target |
| 07/10/2008 | US20080166813 Human OX2 receptors |
| 07/10/2008 | US20080166803 Nucleotide sequences coding cyclic nucleotide-gated channels for use in idenntifying modulators for prevention and treatment of cardiovascular, respiratory, cell proliferative and nervous system disorders |
| 07/10/2008 | US20080166799 Fluorescent protein |
| 07/10/2008 | US20080166798 Trimerizing Polypeptides and Their Uses |
| 07/10/2008 | US20080166783 In vivo incorporation of unnatural amino acids |
| 07/10/2008 | US20080166775 P ef-tu expression units |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
| 07/10/2008 | US20080166763 Human toll homologues |
| 07/10/2008 | US20080166757 Chimeric polypeptide comprising phosphodiesterase and/or lipase A signal sequences for enhancing cytosolic protein transfer |
| 07/10/2008 | US20080166755 Intracellular delivery of osteoinductive proteins and peptides |
| 07/10/2008 | US20080166754 Plant caffeic acid-3-O-methyltransferase homologs |
| 07/10/2008 | US20080166749 Fluorescent Protein Sensors of Post-Translational Modifications |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166739 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166469 Preparation of Canola Protein Isolate and Use in Aquacultre |
| 07/10/2008 | US20080166392 Synthetic peptides having non-growth factor heparin binding region, linker, and sequences that bind specifically to receptor; degenerative joint disease |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166376 Nucleic acids, proteins and vectors containing a nucleotide sequence encoding a full-length or a truncated form of the 60kCRMP gene product of a strain of Chlamydia; vaccines |
| 07/10/2008 | US20080166375 Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166371 HPV31(human papillomavirus) virus-like particles (VLPs); vaccines and drugs for preventing hepatitis |
| 07/10/2008 | US20080166370 Immunogenic Compositions Comprising Multiple Gonococcal Antigens |
| 07/10/2008 | US20080166364 Conjugated to antibody; thrombospondin receptor targeting |
| 07/10/2008 | US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies |
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080166340 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapeutics and cancer |
| 07/10/2008 | US20080166338 Il-21 as a regulator of immunoglobin production |
| 07/10/2008 | US20080166319 Modified cytokine for use in treatment and prevention of viral infection, cell proliferative and autoimmune diseases |
| 07/10/2008 | US20080166300 Screening for agents that modulate a cancer associated phosphatase function; combining a candidate biologically active agent with a polypeptide having phosphatase activity; assessing the effectiveness on cancer cells |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080163823 Polynucleotides, Polypeptides and Method for Screening for Useful Dog Candidates |
| 07/10/2008 | CA2674304A1 Methods and compositions for enhanced protein expression and purification |
| 07/10/2008 | CA2674244A1 Identification of multivalent viral envelope protein epitopes |
| 07/10/2008 | CA2674188A1 Treatment of prdc in pigs |
| 07/10/2008 | CA2674112A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 07/10/2008 | CA2673996A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| 07/10/2008 | CA2673968A1 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto |
| 07/10/2008 | CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | CA2673432A1 Detection of individual t-cell reaction patterns against tumor-associated antigens (taa) in tumor patients as a basis for the individual therapeutic vaccination of patients |
| 07/10/2008 | CA2673310A1 Novel specific arabinose transporter from the yeast pichia stipitis and uses thereof |
| 07/10/2008 | CA2670658A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/09/2008 | EP1942198A2 P-ET-TS expression units in Corynebacterium Glutamicum |
| 07/09/2008 | EP1942190A2 Immoglobulin fusion proteins having modified effector functions and uses thereof |
| 07/09/2008 | EP1942189A2 Method for producing secreted proteins |
| 07/09/2008 | EP1942188A1 Recombinant viral proteins and particles |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942186A2 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 07/09/2008 | EP1942183A1 A mutant acetolactate synthase and a method for producing branched-chain L-amino acids |
| 07/09/2008 | EP1942181A1 Bacterium causing poultry disease and vaccine derived thereof |
| 07/09/2008 | EP1942115A1 Agglutinable glp-1 analogue and sustained-release pharmaceutical composition |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1942113A1 Neuronal differentiation inhibitor peptide and use thereof |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941904A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
| 07/09/2008 | EP1941903A1 Prophylaxis and treatment of PRDC |
| 07/09/2008 | EP1941900A1 Novel exendin agonist compounds |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/09/2008 | EP1941274A1 Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |
| 07/09/2008 | EP1941045A1 A transgenic plant having enhanced drought tolerance |
| 07/09/2008 | EP1941044A2 Cell-based p38 mapk translocation assay |
| 07/09/2008 | EP1941033A2 Compositions and methods for the treatment of canine influenza virus disease |
| 07/09/2008 | EP1941029A2 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 07/09/2008 | EP1941009A2 Use of proteins as an antifoaming constituent in fuels |
| 07/09/2008 | EP1940880A2 Treating diabetes using inhibitors of il-1 |
| 07/09/2008 | EP1940877A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 07/09/2008 | EP1940876A1 Gpr 26 g-protein coupled receptor |
| 07/09/2008 | EP1940875A2 Fibroblast growth factor receptor-derived peptides |
| 07/09/2008 | EP1940874A2 Botulinum neurotoxin a protein receptor and uses thereof |
| 07/09/2008 | EP1940873A2 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 |
| 07/09/2008 | EP1940872A1 Peptides exhibiting efficacies of improvement in skin conditions or treatment of periodental diseases |
| 07/09/2008 | EP1940871A2 Protease-resistant forms of vegf-d, method of making and method of use |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940869A2 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 07/09/2008 | EP1940868A2 Polynucleotides encoding phenylpropanoid pathway enzymes in coffee |
| 07/09/2008 | EP1940867A2 Hiv gp120 crystal structure and its use to identify immunogens |